In the world of healthcare, there’s a currently prevailing issue that concerns healthcare policymakers, hospital administrators, and infection prevention professionals alike. Hospital-acquired infections, which are an ever-present danger for patients, pose a particular challenge to hospital administration as federal penalties are levied on hospitals with high rates of these infections.
The issue stares at a problematic circumstance – on occasions, instead of swiftly testing and treating the patient showing signs of a potentially lethal infection, hospitals hesitate. The reason? It is frequently financial, grounded in the fear of substantial fines charged by federal regulators for patients contracting hospital-acquired infections.
This fear has led to a worrying trend. In a bid to avoid detection of such infections, some hospitals, as reported by clinicians, discourage the very testing that can lead to accurate treatment. This alarming practice can prevent patients from receiving the medical care they need promptly. Furthermore, accusations surface that hospital executives have pressured employees not to report infections to government bodies.
Even more concerning is that regulators have been aware of this issue for a decade, yet neither Medicare nor Congress have implemented remedial actions to fix this harmful practice. According to Carol McLay, president of the Association for Professionals in Infection Control and Epidemiology, this is healthcare’s ‘dirty little secret,’ a widely known yet seldom discussed problem.
As infection prevention professionals, it is crucial to address this issue head-on and work collaboratively to create an environment that prioritizes patient safety and fosters strict adherence to infection control guidelines without fear of economic retribution.